The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000
Open accessAbstract
BACKGROUND: In recent years, there has been a paradigm shift in the method of healthcare delivery to amyotrophic lateral sclerosis (ALS) patients with the emergence of multidisciplinary ALS clinics that cater exclusively for patients with this condition. The impact of multidisciplinary management has not been previously evaluated. METHODS: Using data from the Irish ALS Register, we conducted a prospective, population based study of all ALS cases diagnosed in Ireland over a five year period to evaluate the effectiveness of a multidisciplinary clinic on ALS survival. RESULTS: Eighty two (24%) patients attended the multidisciplinary ALS clinic, with the remaining 262 (76%) cases followed in a general neurology clinic. The ALS clinic cohort was an average of five years younger (60.1 v 65.6 years) and were more likely to receive riluzole than the general neurology cohort (99% v 61%). The median survival of the ALS clinic cohort was 7.5 months longer than for patients in the general neurology cohort (logrank = 15.4, p < 0.0001). Overall, one year mortality was decreased by 29.7%. Prognosis of bulbar onset patients was extended by 9.6 months if they attended the ALS clinic. Using multivariate analysis, attendance at the ALS clinic was an independent covariate of survival (HR = 1.47, p = 0.02). CONCLUSIONS: ALS patients who received their care at a multidisciplinary clinic had a better prognosis than patients attending a general neurology clinic. The data suggest that active and aggressive management enhances survival, particularly among ALS patients with bulbar dysfunction. The effect of clinic type must be considered in future clinical trials design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,140
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Miller, R. G., Rosenberg, J. A., Gelinas, D. F., Mitsumoto, H., Newman, D., Sufit, R., Borasio, G. D., Bradley, W. G., Bromberg, M. B., Brooks, B. R., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1311 · Cited by 574
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
Cudkowicz, M. E., McKenna‐Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410212 · Cited by 533
Clinical limits of amyotrophic lateral sclerosis.
Mulder, D. W. (1982) · PubMed · Cited by 440
American Academy of Neurology: No Scientific Evidence That Ultrasound Can Aid in Diagnosis
&NA; (1998) · The Back Letter · doi:10.1097/00130561-199809000-00009 · Cited by 386
Cited by
Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
Prognostic factors in ALS: A critical review
Chiò, A., Logroscino, G., Hardiman, O., Swingler, R., Mitchell, D., Beghi, E., Traynor, B. G., & On Behalf of the Eurals Consortium (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802566824 · Cited by 1,172
Self-citationThe EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
A comprehensive review of amyotrophic lateral sclerosis
Zarei, S., Carr, K., Reiley, L., Diaz, K., Guerra, O., Altamirano, P., Pagani, W., Lodin, D., Orozco, G., & Chinea, A. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.169561 · Cited by 709
Miller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc01a4 · Cited by 674
Clinical diagnosis and management of amyotrophic lateral sclerosis
Hardiman, O., van den Berg, L. H., & Kiernan, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.153 · Cited by 621
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
Logroscino, G., Traynor, B. J., Hardiman, O., Chio', A., Couratier, P., Mitchell, J. D., Swingler, R. J., Beghi, E., & EURALS, F. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104828 · Cited by 448
Self-citationMultidisciplinary ALS care improves quality of life in patients with ALS
Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J. H. J., & Van den Berg, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000180717.29273.12 · Cited by 343
Multidisciplinary cancer conferences: A systematic review and development of practice standards
Wright, F. C., De Vito, C., Langer, B., & Hunter, A. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.01.025 · Cited by 307
Andersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh, P. N., Pradat, P. ‐., Silani, V., & Tomik, B. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2005.01351.x · Cited by 289
AP-HP, H. D. L. P.-S., & Gordon, P. (2013) · Aging and Disease · doi:10.14336/ad.2013.0400295 · Cited by 277
Oliver, D. J., Borasio, G. D., Caraceni, A., de Visser, M., Grisold, W., Lorenzl, S., Veronese, S., & Voltz, R. (2016) · European Journal of Neurology · doi:10.1111/ene.12889 · Cited by 260
Diagnosis and management of motor neurone disease
McDermott, C. J., & Shaw, P. J. (2008) · BMJ · doi:10.1136/bmj.39493.511759.be · Cited by 220
Rate of disease progression: A prognostic biomarker in ALS
Labra, J., Menon, P., Byth, K., Morrison, S., & Vucic, S. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310998 · Cited by 209
Kurt, A., Nijboer, F., Matuz, T., & K??bler, A. (2007) · CNS Drugs · doi:10.2165/00023210-200721040-00003 · Cited by 177
ALS and other motor neuron diseases
Tiryaki, E., & Horak, H. A. (2014) · Continuum · doi:10.1212/01.con.0000455886.14298.a4 · Cited by 143
Bede, P., Oliver, D., Stodart, J., van den Berg, L., Simmons, Z., O Brannagain, D., Borasio, G. D., & Hardiman, O. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.232637 · Cited by 123
Self-citationAmyotrophic lateral sclerosis and palliative care: where we are, and the road ahead
Blackhall, L. J. (2012) · Muscle & Nerve · doi:10.1002/mus.22305 · Cited by 88
The Dynamics of Quality of Life in ALS Patients and Caregivers
Roach, A. R., Averill, A. J., Segerstrom, S. C., & Kasarskis, E. J. (2009) · Annals of Behavioral Medicine · doi:10.1007/s12160-009-9092-9 · Cited by 81
Exerting control and adapting to loss in amyotrophic lateral sclerosis
Foley, G., Timonen, V., & Hardiman, O. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.11.003 · Cited by 76
Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis
Okada, M., Yamashita, S., Ueyama, H., Ishizaki, M., Maeda, Y., & Ando, Y. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.05.001 · Cited by 68
Andrews, J. A., Berry, J. D., Baloh, R. H., Carberry, N., Cudkowicz, M. E., Dedi, B., Glass, J., Maragakis, N. J., Miller, T. M., Paganoni, S., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.26989 · Cited by 57
Marin, B., Arcuti, S., Jesus, P., Logroscino, G., Copetti, M., Fontana, A., Nicol, M., Raymondeau, M., Desport, J. C., Preux, P. M., et al. (2016) · Neurodegenerative Diseases · doi:10.1159/000442444 · Cited by 48
Clare, L., Teale, J. C., Toms, G., Kudlicka, A., Evans, I., Abrahams, S., Goldstein, L. H., Hindle, J. V., Ho, A. K., Jahanshahi, M., et al. (2019) · NeuroRehabilitation · doi:10.3233/nre-172353 · Cited by 37
Status of ALS treatment, insights into therapeutic challenges and dilemmas
Khamaysa, M., & Pradat, P.-F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101601 · Cited by 28
“Only the significant improvement in the symptomatic treatment of ALS had a significant impact on patient survival and quality of life [4].”
BackgroundFoley, G., Timonen, V., & Hardiman, O. (2012) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909111423774 · Cited by 21
Metadata
- Authors
- Traynor, B. J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2003-09-01
- Volume
- 74
- Issue
- 9
- Pages
- 1258-1261
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2164229456
- Cited by
- 493
- References
- 21
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.